Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FDA
Pharma
Outlook wins FDA appeal after formal dispute proceedings
After a formal dispute resolution process, the FDA has decided that Outlook's eye drug candidate Lytenava has shown evidence of effectiveness.
Zoey Becker
May 27, 2026 8:26am
Fierce Biotech
FDA delays ruling on AstraZeneca drug after negative adcomm vote
May 27, 2026 4:43am
Regulatory tracker: Braftovi nets colorectal cancer wins abroad
May 26, 2026 11:08am
EU regulator recommends AZ's Etcamah, Novo's Wegovy pill
May 22, 2026 11:58am
AZ, Daiichi's Datroway approved in first-line TNBC
May 22, 2026 11:32am
Trial results set up BioMarin for expansion of Voxzogo
May 21, 2026 10:23am
